BRFH

SEC source: 0001493152-21-017155 · ownership.xml · nonDerivative · entry 3

UNIBEL · CIK 0001240037 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,329,548

F2 · price: On March 19, 2020, the reporting person converted its $600,000 M1 convertible note and $400,000 M2 convertible note into common stock. The O Warrants were issued for participation in the conversion.

SEC source: 0001493152-21-017155 · ownership.xml · nonDerivative · entry 2

UNIBEL · CIK 0001240037 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,265,000

F2 · price: On March 19, 2020, the reporting person converted its $600,000 M1 convertible note and $400,000 M2 convertible note into common stock. The O Warrants were issued for participation in the conversion.

SEC source: 0001493152-23-006860 · ownership.xml · derivative · entry 15

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · RD Capital Holdings Pty Ltd

Disclosed balance after: 2,308

Underlying: Common Stock · 2,308 shares

Expires 2023-03-23

F4 · price: On March 23, 2020, RD Capital Holdings Pty Ltd received shares of common stock upon conversion of its convertible note and warrants for participation in the conversion.

SEC source: 0001079973-20-000204 · ownership.xml · derivative · entry 4

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Justin Borus

Disclosed balance after: 1,500,000

Underlying: Common Stock · 1,500,000 shares

Expires 2023-04-15

F3 · derivative.exercise_price: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · derivative.exercise_price: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · derivative.exercise_price: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F3 · kind: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · kind: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · kind: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F3 · shares: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · shares: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · shares: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F3 · price: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · price: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · price: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F6 · derivative.exercise_date: The warrant will be exercisable immediately upon acquisition at the closing of the SPA, which is expected to be on or about April 15, 2020, for a period of three years thereafter. If the SPA does not close precisely on April 15, 2020, this Form 4 will be amended accordingly.

F6 · derivative.expiration_date: The warrant will be exercisable immediately upon acquisition at the closing of the SPA, which is expected to be on or about April 15, 2020, for a period of three years thereafter. If the SPA does not close precisely on April 15, 2020, this Form 4 will be amended accordingly.

F3 · derivative.underlying_shares: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · derivative.underlying_shares: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · derivative.underlying_shares: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F1 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex. Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. (continued in footnote 2)

F2 · ownership.nature: Ibex and each of the Funds expressly disclaims beneficial ownership of the securities held by Mr. Borus. The filing of this Form 4 shall not be construed as an admission that any Reporting Person, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein other than the securities held directly by such Reporting Person.

SEC source: 0001079973-20-000204 · ownership.xml · nonDerivative · entry 1

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Justin Borus

Disclosed balance after: 3,000,000

F3 · kind: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · kind: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · kind: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F3 · shares: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · shares: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · shares: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F3 · price: On March 19, 2020, Mr. Borus entered into a Securities Purchase Agreement (the "SPA") with the Issuer whereby Mr. Borus agreed to purchase, for an aggregate purchase price of $1,500,000, 3,000,000 shares of Common Stock and warrants to purchase an additional 1,500,000 shares of Common Stock; provided that if the volume-weighted average trading price for the last twenty (20) consecutive trading days that conclude the six (6) month period after the initial closing under the SPA (the "Six Month Price") is less than $0.50 per share (the "Target Price"), the per share purchase price for the Common Stock will be automatically reduced to the Six Month Price, but in no event less than $0.35 per Share, in which case the Issuer shall issue to Mr. Borus, based on Mr. Borus' investment: (continued in footnote 4)

F4 · price: (a) shares of Common Stock in a quantity that equals the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price; and (b) a warrant for a number of warrant shares equal to fifty percent (50%) of the difference between the number of shares of Common Stock issued to Mr. Borus at closing and the number of shares of Common Stock that would have been issued to Mr. Borus at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. (continued in footnote 5)

F5 · price: The exercise price per share for the warrant issued at closing will automatically adjust to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. Mr. Borus expects the purchase under the SPA to close on or about April 15, 2020; if such purchase does not close for whatever reason, a Form 4 will be filed to rescind the transactions reported under this Form 4.

F1 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex. Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. (continued in footnote 2)

F2 · ownership.nature: Ibex and each of the Funds expressly disclaims beneficial ownership of the securities held by Mr. Borus. The filing of this Form 4 shall not be construed as an admission that any Reporting Person, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein other than the securities held directly by such Reporting Person.

SEC source: 0001493152-21-017155 · ownership.xml · derivative · entry 6

UNIBEL · CIK 0001240037 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,252,274

Underlying: Common Stock · 1,252,274 shares

Expires 2023-03-19

F2 · price: On March 19, 2020, the reporting person converted its $600,000 M1 convertible note and $400,000 M2 convertible note into common stock. The O Warrants were issued for participation in the conversion.

SEC source: 0001493152-21-016278 · ownership.xml · nonDerivative · entry 4

Lang Steven · CIK 0001598907 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Hodumo Pty Ltd

Disclosed balance after: 60,000

F3 · price: Shares were issued in lieu of interest on its M1 convertible note, valued according to the terms of the note at $0.60 per share.

SEC source: 0001493152-20-007682 · ownership.xml · nonDerivative · entry 2

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · R.D. Capital Holdings PTY Ltd.

Disclosed balance after: 19,448,341

F2 · shares: Milestone conversion into offering

SEC source: 0001493152-21-011002 · ownership.xml · nonDerivative · entry 4

Cugine Joseph M. · CIK 0001557753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,862,689

SEC source: 0001493152-21-017155 · ownership.xml · nonDerivative · entry 1

UNIBEL · CIK 0001240037 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,825,000

F1 · price: The reporting person received 200,000 shares of common stock in payment of interest on its M1 convertible note, valued according to the terms of the note at $0.60 per share.

SEC source: 0001493152-21-004120 · ownership.xml · derivative · entry 3

Ortiz-Cochet Isabelle · CIK 0001692794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,899

Underlying: Common Stock · 96,899 shares

Expires 2028-01-15

F1 · price: Stock option granted as non-employee director board compensation.

SEC source: 0001493152-21-004127 · ownership.xml · nonDerivative · entry 3

WARE ALEXANDER H · CIK 0001212143 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 506,947

F1 · price: Represents director's compensation granted in stock pursuant to the Issuer's compensation plan for non-employee directors.

F2 · ownership.nature: Reporting person exercises voting and dispositive power as trustee of Alexander Ware Revocable Trust u/a/d 12/29/04.

SEC source: 0001493152-21-004127 · ownership.xml · nonDerivative · entry 2

WARE ALEXANDER H · CIK 0001212143 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 435,518

F1 · price: Represents director's compensation granted in stock pursuant to the Issuer's compensation plan for non-employee directors.

F2 · ownership.nature: Reporting person exercises voting and dispositive power as trustee of Alexander Ware Revocable Trust u/a/d 12/29/04.

SEC source: 0001493152-21-004120 · ownership.xml · derivative · entry 2

Ortiz-Cochet Isabelle · CIK 0001692794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,411

Underlying: Common Stock · 48,411 shares

Expires 2027-07-15

F1 · price: Stock option granted as non-employee director board compensation.

SEC source: 0001493152-21-016278 · ownership.xml · derivative · entry 15

Lang Steven · CIK 0001598907 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,769

Underlying: Common Stock · 71,769 shares

Expires 2027-07-15

F6 · price: Stock option granted as non-employee director compensation.

SEC source: 0001493152-19-014941 · ownership.xml · derivative · entry 11

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,925,000

Underlying: Common Stock · 250,000 shares

Expires 2027-04-28

F3 · price: Grant for services

SEC source: 0001493152-19-014941 · ownership.xml · derivative · entry 4

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 870,777

Underlying: Common Stock · 731,635 shares

Expires 2024-03-31

F6 · price: Payment of deferred compensation

SEC source: 0001493152-21-011002 · ownership.xml · derivative · entry 12

Cugine Joseph M. · CIK 0001557753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,798

Underlying: Common Stock · 273,798 shares

Expires 2028-03-29

F8 · price: Payment of deferred compensation.

SEC source: 0001493152-21-004127 · ownership.xml · nonDerivative · entry 1

WARE ALEXANDER H · CIK 0001212143 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 382,327

F1 · price: Represents director's compensation granted in stock pursuant to the Issuer's compensation plan for non-employee directors.

F2 · ownership.nature: Reporting person exercises voting and dispositive power as trustee of Alexander Ware Revocable Trust u/a/d 12/29/04.

SEC source: 0001493152-21-016278 · ownership.xml · derivative · entry 14

Lang Steven · CIK 0001598907 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,711

Underlying: Common Stock · 53,711 shares

Expires 2027-01-16

F6 · price: Stock option granted as non-employee director compensation.

SEC source: 0001493152-21-004120 · ownership.xml · derivative · entry 1

Ortiz-Cochet Isabelle · CIK 0001692794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,711

Underlying: Common Stock · 53,711 shares

Expires 2027-01-15

F1 · price: Stock option granted as non-employee director board compensation.

SEC source: 0001493152-21-016278 · ownership.xml · nonDerivative · entry 3

Lang Steven · CIK 0001598907 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Sidra Pty Ltd

Disclosed balance after: 19,127,177

F2 · price: Shares were acquired through a cashless exercise of a warrant.

SEC source: 0001567619-18-008539 · doc1.xml · derivative · entry 2

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 833,333 shares

Expires 2018-12-20

F2 · price: These Warrants were acquired from the Issuer together with a promissory note in the principal amount of $500,000 for a total transaction price of $500,000.

F1 · derivative.exercise_date: These Warrants are not exercisable by the holder to the extent (but only to the extent) that the holder together with any of its affiliates would beneficially own in excess of 9.99% (the "Maximum Percentage") of the Issuer's Common Stock after giving effect to such exercise and as a result of such exercise. By written notice to the Issuer, the holder may increase or decrease the Maximum Percentage, as applied to the holder, to any other percentage specified in such notice; provided that any such increase will not be effective until the 61st day after such notice is delivered to the Issuer.

F3 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F4 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001567619-18-008539 · doc1.xml · nonDerivative · entry 1

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 14,445,766

F3 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F4 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001493152-19-000227 · ownership.xml · nonDerivative · entry 1

Tesoriero Joseph S. · CIK 0001474867 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 489,345

F1 · price: Represents vesting of 18,044 shares subject to a restricted stock award granted on December 12, 2016.

SEC source: 0001493152-21-011002 · ownership.xml · nonDerivative · entry 3

Cugine Joseph M. · CIK 0001557753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,852,689

F2 · price: Represents vesting of restricted stock award granted on December 12, 2016.

SEC source: 0001493152-19-014941 · ownership.xml · derivative · entry 5

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,142

Underlying: Common Stock · 6,720 shares

Expires 2021-11-30

F4 · price: Investment in convertible note

SEC source: 0001493152-21-011002 · ownership.xml · derivative · entry 11

Cugine Joseph M. · CIK 0001557753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,720

Underlying: Common Stock · 6,720 shares

Expires 2021-11-30

F7 · price: On November 30, 2018, Mr. Cugine purchased a convertible and warrants, convertible and exercisable at a trailing average price between $0.88 and $0.60 per share.

SEC source: 0001493152-21-016278 · ownership.xml · derivative · entry 13

Lang Steven · CIK 0001598907 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Hodumo Pty Ltd

Disclosed balance after: 80,645

Underlying: Common Stock · 80,645 shares

Expires 2021-11-30

F7 · price: Issued in connection with investment in note.

SEC source: 0001493152-21-017155 · ownership.xml · derivative · entry 5

UNIBEL · CIK 0001240037 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,409

Underlying: Common Stock · 134,409 shares

Expires 2021-11-30

F4 · derivative.exercise_price: On November 30, 2018, the reporting person purchased a convertible note and warrants, convertible and exercisable at the greater of 120% of the Closing Price or $0.70.

F4 · price: On November 30, 2018, the reporting person purchased a convertible note and warrants, convertible and exercisable at the greater of 120% of the Closing Price or $0.70.

SEC source: 0001140361-18-034253 · doc1.xml · derivative · entry 5

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,800,000

Underlying: Common Stock · 1,800,000 shares

Expires 2021-07-31

F1 · kind: On July 26, 2018, the terms of an aggregate of 1,800,000 warrants were amended to extend the expiration date to July 31, 2021 and change the exercise price to $0.53 per share.

F4 · price: This Warrant is the amended Warrant, resulting from the amendment that is described in Footnote 1.

F2 · derivative.exercise_date: These Warrants are not exercisable by the holder to the extent (but only to the extent) that the holder together with any of its affiliates would beneficially own in excess of 9.99% (the "Maximum Percentage") of the Issuer's Common Stock after giving effect to such exercise and as a result of such exercise. By written notice to the Issuer, the holder may increase or decrease the Maximum Percentage, as applied to the holder, to any other percentage specified in such notice; provided that any such increase will not be effective until the 61st day after such notice is delivered to the Issuer.

F5 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F6 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001140361-18-034253 · doc1.xml · derivative · entry 4

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2018-08-05

F1 · kind: On July 26, 2018, the terms of an aggregate of 1,800,000 warrants were amended to extend the expiration date to July 31, 2021 and change the exercise price to $0.53 per share.

F3 · price: These Warrants were originally acquired from the Issuer as part of Units, each consisting of one share of Common Stock, one such Warrant and one other Warrant (each a "Unit"). The price paid for each Unit was $0.25.

F2 · derivative.exercise_date: These Warrants are not exercisable by the holder to the extent (but only to the extent) that the holder together with any of its affiliates would beneficially own in excess of 9.99% (the "Maximum Percentage") of the Issuer's Common Stock after giving effect to such exercise and as a result of such exercise. By written notice to the Issuer, the holder may increase or decrease the Maximum Percentage, as applied to the holder, to any other percentage specified in such notice; provided that any such increase will not be effective until the 61st day after such notice is delivered to the Issuer.

F5 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F6 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001140361-18-034253 · doc1.xml · derivative · entry 3

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 1,700,000 shares

Expires 2018-07-26

F1 · kind: On July 26, 2018, the terms of an aggregate of 1,800,000 warrants were amended to extend the expiration date to July 31, 2021 and change the exercise price to $0.53 per share.

F3 · price: These Warrants were originally acquired from the Issuer as part of Units, each consisting of one share of Common Stock, one such Warrant and one other Warrant (each a "Unit"). The price paid for each Unit was $0.25.

F2 · derivative.exercise_date: These Warrants are not exercisable by the holder to the extent (but only to the extent) that the holder together with any of its affiliates would beneficially own in excess of 9.99% (the "Maximum Percentage") of the Issuer's Common Stock after giving effect to such exercise and as a result of such exercise. By written notice to the Issuer, the holder may increase or decrease the Maximum Percentage, as applied to the holder, to any other percentage specified in such notice; provided that any such increase will not be effective until the 61st day after such notice is delivered to the Issuer.

F5 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F6 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001140361-18-034253 · doc1.xml · derivative · entry 2

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,700,000

Underlying: Common Stock · 1,100,000 shares

Expires 2018-07-26

F3 · price: These Warrants were originally acquired from the Issuer as part of Units, each consisting of one share of Common Stock, one such Warrant and one other Warrant (each a "Unit"). The price paid for each Unit was $0.25.

F2 · derivative.exercise_date: These Warrants are not exercisable by the holder to the extent (but only to the extent) that the holder together with any of its affiliates would beneficially own in excess of 9.99% (the "Maximum Percentage") of the Issuer's Common Stock after giving effect to such exercise and as a result of such exercise. By written notice to the Issuer, the holder may increase or decrease the Maximum Percentage, as applied to the holder, to any other percentage specified in such notice; provided that any such increase will not be effective until the 61st day after such notice is delivered to the Issuer.

F5 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F6 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001140361-18-034253 · doc1.xml · nonDerivative · entry 1

Ibex Investors LLC · CIK 0001531964 · 10% owner

Ibex Microcap Fund LLLP · CIK 0001232118 · 10% owner

Lazarus Macro Micro Partners LLLP · CIK 0001639757 · 10% owner

BORUS JUSTIN B · CIK 0001531960 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 13,612,433

F5 · ownership.nature: This form is filed jointly by Ibex Investors LLC ("Ibex"), Justin B. Borus, Ibex Microcap Fund LLLP ("Ibex Microcap") and Lazarus Macro Micro Partners LLLP ("Macro Micro Partners" and together with Ibex Microcap, the "Funds"). The securities reported herein are owned directly by Ibex Microcap except for 3,000 shares of common stock owned directly by Macro Micro Partners. Ibex is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Ibex.

F6 · ownership.nature: Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

SEC source: 0001493152-19-000227 · ownership.xml · derivative · entry 3

Tesoriero Joseph S. · CIK 0001474867 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common stock · 250,000 shares

Expires 2026-07-26

F3 · price: Stock option grant vesting in equal increments on 7/26/19, 7/26/20, and 7/26/21.

F3 · derivative.exercise_date: Stock option grant vesting in equal increments on 7/26/19, 7/26/20, and 7/26/21.

SEC source: 0001493152-21-011002 · ownership.xml · derivative · entry 9

Cugine Joseph M. · CIK 0001557753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2026-07-26

F5 · price: Performance options granted pursuant to executive employment agreement. Option vests in equal amounts annually over three years begining on the first anniversary of the grant date.

F5 · derivative.exercise_date: Performance options granted pursuant to executive employment agreement. Option vests in equal amounts annually over three years begining on the first anniversary of the grant date.

SEC source: 0001493152-19-000395 · ownership.xml · nonDerivative · entry 1

WARE ALEXANDER H · CIK 0001212143 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 343,865

F1 · price: Represents director's compensation granted in stock pursuant to the Issuer's compensation plan for non-employee directors.

F2 · ownership.nature: Reporting person exercises voting and dispositive power as trustee of Alexander Ware Revocable Trust u/a/d 12/29/04.

SEC source: 0001493152-19-000538 · ownership.xml · nonDerivative · entry 1

Elliot Alice · CIK 0001632920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558,236

F1 · price: Represents director's compensation granted in stock pursuant to the Issuer's compensation plan for non-employee directors.

SEC source: 0001493152-19-000560 · ownership.xml · derivative · entry 1

Ortiz-Cochet Isabelle · CIK 0001692794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,832

Underlying: Common stock · 59,023 shares

Expires 2026-07-16

F1 · price: Stock option granted as non-employee director board compensation.

SEC source: 0001493152-21-016278 · ownership.xml · derivative · entry 12

Lang Steven · CIK 0001598907 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,023

Underlying: Common Stock · 59,023 shares

Expires 2026-07-16

F6 · price: Stock option granted as non-employee director compensation.

SEC source: 0001493152-19-000227 · ownership.xml · nonDerivative · entry 2

Tesoriero Joseph S. · CIK 0001474867 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 471,301

F2 · price: Represents vesting of restricted stock award granted on May 8, 2015 pursuant to the reporting persons' executive employment contract.

SEC source: 0001493152-21-011002 · ownership.xml · nonDerivative · entry 2

Cugine Joseph M. · CIK 0001557753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,829,414

F1 · price: Represents vesting of restricted stock award granted on May 8, 2015.

SEC source: 0001493152-19-014941 · ownership.xml · derivative · entry 12

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,675,000

Underlying: Common Stock · 250,000 shares

Expires 2026-04-27

F3 · price: Grant for services

SEC source: 0001493152-19-014941 · ownership.xml · derivative · entry 6

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,422

Underlying: Common Stock · 15,646 shares

Expires 2021-03-14

F4 · price: Investment in convertible note

SEC source: 0001493152-19-014941 · ownership.xml · derivative · entry 7

Delle Coste Riccardo · CIK 0001598573 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 116,776

Underlying: Common Stock · 15,646 shares

Expires 2021-03-13

F4 · price: Investment in convertible note

F2 · ownership.nature: Held by the R.D. Capital Holdings PTY Ltd.

SEC source: 0001493152-19-000538 · ownership.xml · nonDerivative · entry 2

Elliot Alice · CIK 0001632920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 508,633

F1 · price: Represents director's compensation granted in stock pursuant to the Issuer's compensation plan for non-employee directors.

SEC source: 0001493152-18-002985 · form4.xml · nonDerivative · entry 3

WARE ALEXANDER H · CIK 0001212143 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · see footnote

Disclosed balance after: 301,848

F5 · price: Represents director's fees of $25,000 for the first half of 2018 paid in stock pursuant to the Issuer's compensation plan for non-employee directors.

F3 · ownership.nature: Shares are held by the Alexander H. Ware Revocable Trust u/a/d 12/20/04.

SEC source: 0001493152-18-002981 · form-4.xml · nonDerivative · entry 1

Elliot Alice · CIK 0001632920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,630

F1 · price: Represents director's fees of $25,000 for the first half of 2018 paid in stock pursuant to the Issuer's compensation plan for non-employee directors.

SEC source: 0001493152-18-003055 · form4.xml · derivative · entry 3

Ortiz-Cochet Isabelle · CIK 0001692794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,321

Underlying: Common Stock · 44,321 shares

Expires 2026-01-16

F3 · shares: Represents director's fees for the first half of 2018 paid in stock options pursuant to the Issuer's compensation plan for non-employee directors.

F3 · price: Represents director's fees for the first half of 2018 paid in stock options pursuant to the Issuer's compensation plan for non-employee directors.